PT  - JOURNAL ARTICLE
AU  - Moyakhe, L.B.
AU  - Dalvie, S.
AU  - Mufford, M.S.
AU  - Stein, D.J.
AU  - Koen, N.
TI  - Polygenic risk associations with developmental and mental health outcomes in childhood and adolescence: A systematic review
AID  - 10.1101/2023.03.31.23287877
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.31.23287877
4099  - http://medrxiv.org/content/early/2023/03/31/2023.03.31.23287877.short
4100  - http://medrxiv.org/content/early/2023/03/31/2023.03.31.23287877.full
AB  - Background Neurodevelopmental and mental health disorders in childhood constitute an emerging global concern, with adverse sequelae which span children’s physical, psychological and social well-being. The aetiology of these disorders is likely complex, multifactorial and polygenic. Polygenic risk scores (PRS), an estimate of an individual’s genetic liability toward a disorder, have been increasingly used in psychiatric research to explore genetic associations with disorders of interest. However, limited work delineates polygenic associations with development and mental health in childhood populations.We aimed to systematically review existing literature on associations between genetic risk (as measured by PRS) and neurodevelopmental and mental health outcomes in childhood and adolescence.Methods Following the recommended Preferred Reporting Items for Meta-Analyses (PRISMA) guidelines, databases were searched using key search terms. The search commenced in March 2021 and concluded in June 2021. The studies eligible for inclusion were full-text articles investigating polygenic risk associations with neurodevelopmental and/or mental health outcomes in childhood or adolescence.Results Fourteen studies were eligible for inclusion in this systematic review. The association between higher PRS for attention-deficit/hyperactivity disorder (ADHD) and adverse developmental/mental health outcomes in childhood and adolescence was reported by five studies. Additionally, associations between PRS for bipolar disorder or major depressive disorder and adverse outcomes of interest were also described by two studies; and two studies highlighted associations between schizophrenia PRS and mental health disorders in childhood. The remaining studies highlighted shared polygenic contributions between and within NDDs and mental health disorders in children.Conclusion The findings of this systematic review suggest that PRS for neurodevelopmental and mental health disorders may associate with adverse neurodevelopmental and mental health outcomes from early childhood to adolescence. In addition, these associations seemed not to be phenotype-specific, suggesting potential shared genetic variation across the phenotypes of interest.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe funders had no role in the study design, analysis, and interpretation of data; writing of the report; and decision to submit the article for publication. However, L.B. Moyakhe is a recipient of the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Internship Scholarship Program.M.S. Mufford is supported by the South African National Research Fund, the David and Elaine Potter Foundation and the Global Initiative for Neuropsychiatric Genetics Education in Research (GINGER) program. The GINGER program is partially supported by an award from the National Institute for Mental Health (1R01MH120642). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the source data are openly available and references to the individual studies reviewed are provided in the manuscript.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll the information produced in the present study is contained within the manuscript, however, upon reasonable request, additional details can be provided by the authors.